OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Janjigian on Pembrolizumab Triplet in HER2+ Esophagogastric Cancer

June 17th 2020

Yelena Y. Janjigian, MD, discusses the rationale behind the plasma and tumor-based biomarker analysis of pembrolizumab in combination with trastuzumab and chemotherapy in HER2-positive metastatic esophagogastric cancer.

Dr. Lee on the Combination of Immunotherapy and TKIs in mRCC

June 17th 2020

Chung-Han Lee, MD, PhD, discusses the efficacy of combining immunotherapy with TKIs to treat patients with metastatic renal cell carcinoma.

Dr. Daver on the Mechanism of Action of Magrolimab in AML/MDS

June 17th 2020

Naval G. Daver, MD, discusses the mechanism of action of the investigational CD47-directed antibody magrolimab in acute myeloid leukemia and myelodysplastic syndrome.

Dr. Sartor on Sequential Use of Beta and Alpha Emitters in mCRPC

June 17th 2020

A. Oliver Sartor, MD, discusses the rationale for investigating the sequential use of beta emitters and alpha emitters in metastatic castration-resistant prostate cancer.

Dr. Gafita on Sequencing 177Lu-PSMA-617 in mCRPC

June 17th 2020

Andrei Gafita, MD, discusses sequencing lutetium-177 PSMA-617 in metastatic castration-resistant prostate cancer.

Dr. Cortes on the Benefit of Ruxolitinib in MPNs

June 17th 2020

Jorge E. Cortes, MD, discusses the benefits of ruxolitinib (Jakafi) in patients with myeloproliferative neoplasms.

Dr. Lonial on Emerging Concepts in Multiple Myeloma Treatment

June 17th 2020

Sagar Lonial, MD, FACP, discusses some of the remaining challenges to address in the multiple myeloma space.

Dr. Chi on the Rationale for the PC-BETS Study With ctDNA in Prostate Cancer

June 16th 2020

Kim Chi, MD, senior research scientist, Vancouver Prostate Centre, discusses clinical challenges in prostate cancer.

Dr. Slomovitz on Sequencing Strategies for Endometrial Cancer

June 16th 2020

Brian M. Slomovitz, MD, discusses sequencing strategies for endometrial cancer.

Dr. Gupta on Neoadjuvant Versus Adjuvant Immunotherapy in Urothelial Carcinoma

June 16th 2020

Shilpa Gupta, MD, discusses the potential utility of neoadjuvant versus adjuvant immunotherapy in urothelial carcinoma.

Dr. Coveler on SEA-CD40 Combo in Metastatic Pancreatic Ductal Adenocarcinoma

June 16th 2020

Andrew Coveler, MD, discusses the investigational CD40-directed monoclonal antibody SEA-CD40 in combination with gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma.

Dr. Glitza Oliva on Intrathecal/Intravenous Nivolumab in Metastatic Melanoma/Leptomeningeal Disease

June 16th 2020

Isabella C. Glitza Oliva, MD, PhD, MS, discusses the rationale for concurrent intrathecal and intravenous nivolumab in patients with metastatic melanoma who have leptomeningeal disease.

Dr. Branagan on Novel Induction Therapies With Transplant in Myeloma

June 16th 2020

Andrew Branagan, MD, discusses novel induction therapies being used with transplant to improve outcomes in patients with multiple myeloma.

Dr. Furman on the Safety of Acalabrutinib in Hematologic Malignancies

June 16th 2020

Richard R. Furman, MD, discusses the safety of acalabrutinib as a monotherapy in hematologic malignancies.

Dr. Karmali on Treating Older Patients With MCL in the Rituximab Era

June 16th 2020

Reem Karmali, MD, MS, discusses an analysis examining clinical outcomes and predictors of survival in older patients with mantle cell lymphoma in the era of rituximab.

Dr. Coleman on the Utility of Biomarkers for Precision Medicine in Ovarian Cancer

June 16th 2020

Robert L. Coleman, MD, FACOG, FACS, discusses the utility of biomarkers in precision medicine.

Dr. Gwin on Potential Areas of Investigation With Alpha-TEA/Trastuzumab in Breast Cancer

June 16th 2020

William R. Gwin III, MD, discusses potential areas of investigation with the combination of alpha-tocopheryloxyacetic acid (alpha-TEA) and trastuzumab (Herceptin) in breast cancer.

Dr. Hari on the Current and Potential Future Utility of Ixazomib Maintenance in Myeloma

June 16th 2020

Parameswaran Hari, MD, MRCP, discusses the current and potential future utility of ixazomib (Ninlaro) maintenance in multiple myeloma.

Dr. Kumar on Takeaways From the ENDURANCE Trial in Multiple Myeloma

June 16th 2020

Shaji K. Kumar, MD, discusses key takeaways from the phase 3 ENDURANCE trial in newly diagnosed multiple myeloma.

Dr. Lee on Examining Novel Targets in Lymphomas and Leukemias

June 15th 2020

Hun Ju Lee, MD, discusses novel targets in lymphomas and leukemias.